What is Abivertinib used for?

Abivertinib is being studied for the treatment of non-small cell lung carcinoma, prostate cancer, and COVID-19.

How does Abivertinib work in the body?

It works as an inhibitor for the epidermal growth factor receptor erbB1 and the tyrosine-protein kinase BTK.

Is Abivertinib an oral medication?

The provided data does not specify if Abivertinib is taken by mouth.

What stage of testing is Abivertinib in?

Abivertinib is currently in Phase 3 clinical development for lung cancer and Phase 2 for other conditions.

What are the synonyms for Abivertinib?

Abivertinib is also known by the names A610 and Abive.

Is Abivertinib a small molecule?

Yes, Abivertinib is classified as a small molecule drug.

abivertinib | CAS 1557267-42-1 | UOFYSRZSLXWIQB

Loading compound...

Kinase inhibitor

Abivertinib (also known as A610 or Abive) is a small molecule drug currently being studied in clinical trials. It works by inhibiting specific proteins like the epidermal growth factor receptor (erbB1) and tyrosine-protein kinase BTK. It is being researched for various uses, including non-small cell lung carcinoma, prostate cancer, and COVID-19.

How it worksAbivertinib works by blocking certain proteins (erbB1 and BTK) that help cancer cells grow and spread.

Used for

non-small cell lung carcinomaprostate cancerCOVID-19

Conditions

non-small cell lung carcinomaprostate cancerCOVID-19

Class

erbB1 inhibitorBTK inhibitorSmall moleculeKinase inhibitor

How to take

This drug is currently in clinical development (Phase 3/Phase 2) and is not yet widely available for general use.

Talk to your doctor

Questions to ask

·What phase of clinical trials is Abivertinib currently in?
·How does Abivertinib target my specific type of cancer?
·What are the potential side effects of Abivertinib?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)